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Background: Cardiac arrhythmias represent a significant problem globally, leading to
cerebrovascular accidents, myocardial infarction, and sudden cardiac death. There is
increasing evidence to suggest that increased oxidative stress from reactive oxygen
species (ROS), which is elevated in conditions such as diabetes and hypertension, can
lead to arrhythmogenesis.
Method: A literature review was undertaken to screen for articles that investigated the
effects of ROS on cardiac ion channel function, remodeling and arrhythmogenesis.
Results: Prolonged endoplasmic reticulum stress is observed in heart failure, leading
to increased production of ROS. Mitochondrial ROS, which is elevated in diabetes and
hypertension, can stimulate its own production in a positive feedback loop, termed
ROS-induced ROS release. Together with activation of mitochondrial inner membrane
anion channels, it leads to mitochondrial depolarization. Abnormal function of these
organelles can then activate downstream signaling pathways, ultimately culminating
in altered function or expression of cardiac ion channels responsible for generating
the cardiac action potential (AP). Vascular and cardiac endothelial cells become
dysfunctional, leading to altered paracrine signaling to influence the electrophysiology
of adjacent cardiomyocytes. All of these changes can in turn produce abnormalities in
AP repolarization or conduction, thereby increasing likelihood of triggered activity and
reentry.
Conclusion: ROS plays a significant role in producing arrhythmic substrate.
Therapeutic strategies targeting upstream events include production of a strong reducing
environment or the use of pharmacological agents that target organelle-specific proteins
and ion channels. These may relieve oxidative stress and in turn prevent arrhythmic
complications in patients with diabetes, hypertension, and heart failure.
Keywords: oxidative stress, reactive oxygen species, endoplasmic reticulum, mitochondria, conduction,
repolarization, remodeling, arrhythmia
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INTRODUCTION
Cardio-metabolic disorders such as diabetes mellitus and
hypertension place significant burdens on the healthcare system
worldwide. Over the past decades, their prevalence has been
steadily increasing, due to aging and a rising level of obesity
in the population (Chan and Woo, 2010; Wong et al.,
2011). These disorders are leading causes of mortality and
morbidity, which are traditionally attributed to cardiovascular
accidents, myocardial infarction, and heart failure. Cardiac
arrhythmias have increasingly been recognized as a cause
of death. Diabetes may affect the prognosis of heart failure
subjects differently at the clinical (Sardu et al., 2014b) and
epigenetic level (Sardu et al., 2016). This article explores
the normal functions of the endoplasmic reticulum (ER) and
mitochondria, and synthesize current experimental data to
illustrate how increased oxidative andmetabolic stress can lead to
dysfunction of these organelles, and in turn can initiate signaling
cascades that modify the ion channel function and promote
electrophysiological and structural remodeling, which ultimately
promotes arrhythmogenesis.
NORMAL FUNCTIONS OF THE
ENDOPLASMIC RETICULUM,
SARCOPLASMIC RETICULUM, AND
MITOCHONDRIA
The ER is the intracellular organelle responsible for protein
synthesis, folding, maturation, and assembly before they are
exported to the Golgi apparatus, cytosol and plasma membrane.
The oxidative environment within the lumen ensures proper
formation of tertiary and quaternary structures, aided by
chaperones and abundance of Ca2+ for interactions between
them. Abnormalities in these factors can lead to unfolding
or misfolding of proteins, which in turn can accumulate
within the ER lumen. This would produce ER stress and
elicit the unfolded protein response (UPR), which serves to
reduce protein synthesis, enhance protein folding ability and aid
misfolded or unfolded protein to cellular degradation pathways
(Tsang et al., 2010).
The sarcoplasmic reticulum (SR) of cardiomyocytes is
responsible for excitation-contraction coupling and subsequent
contractile activation. Thus, dihydropyridine receptors (DIHRs)
are found in the transverse tubular system and have molecular
configurations that are steeply voltage-dependent, enabling them
to act as voltage sensors. They are allosterically coupled to RyRs,
the Ca2+ release channels in the SR. A depolarizing wave from the
plasma membrane can spread to the transverse tubules, thereby
activating the DIHRs, which then allows RyRs to dissociate from
DIHRs and release the luminal Ca2+, inducing further release
from the SR by a mechanism called Ca2+-induced Ca2+-release.
This intracellular Ca2+ is important for initiation of contractile
activity, as it binds to Ca2+-sensitive proteins including troponin,
myosin, and actin. Relaxation occurs when intracellular Ca2+
returns to normal levels by following mechanisms: passive eﬄux
mediated by the electrogenic sodium-calcium exchanger (NCX)
out of the cell, active transport into the SR by sarcoplasmic
reticulum Ca2+-ATPase (SERCA) and passive diffusion into the
mitochondria via the mitochondrial Ca2+ uniporter (Choi et al.,
2014). Finally, the SR may have functions that are traditionally
ascribed to the ER, such as protein synthesis and folding
(Glembotski, 2012).
The mitochondria are the site of energy supply where ATP
synthesis occurs by oxidative phosphorylation, with additional
roles such as regulation of apoptosis, redox status and reactive
oxygen species (ROS) production (Dikalov, 2011). ATP synthesis
involves electron transfer through the respiratory chain from
complex I through to complex IV, culminating in protons being
pumped from the mitochondrial matrix into the intermembrane
space (Chance and Williams, 1955). Mitochondria are the main
source of ROS, which are derived mostly from complexes I
and III, as well as enzymes such as the alpha-ketoglutarate
dehydrogenase complex and those involved in fatty acid beta-
oxidation (St-Pierre et al., 2002; Starkov et al., 2004; Tahara
et al., 2009; Brand, 2010). Oxygen free radical production is
much more efficient by reverse electron transfer dependent on
succinate (through complex I to NAD+) than forward electron
transfer with NADH (Panov et al., 2007). This reverse electron
transfer is an important mechanism of ROS production in many
pathological conditions such as hypertension (Nazarewicz et al.,
2013).
INCREASED OXIDATIVE STRESS AND
INTRACELLULAR ORGANELLE
DYSFUNCTION IN CARDIO-METABOLIC
DISORDERS
Increased oxidative stress from excessive ROS production
appears to underlie pro-arrhythmic cardiac modeling in cardio-
metabolic disorders (Figure 1). There is an increased arrhythmic
burden, conditioning primary and secondary outcomes in
patients with metabolic syndrome (Sardu et al., 2014a). ROS
refers to superoxide, hydrogen peroxide, peroxynitrite, and
hydroxyl radicals, which are unstable molecular species that
can damage proteins and lipids within the cell, and activate
intracellular signaling cascades. They can be generated by
activation of NADPH oxidase or xanthine oxidase, uncoupling
of nitric oxide synthase (NOS) or leakage of electrons from
the mitochondria during oxidative phosphorylation. Normally,
cardiomyocytes are protected from ROS-mediated damage
by several mechanisms. Firstly, enzymes such as superoxide
dismutase (SOD), catalase and glutathione peroxidase
breakdown ROS into water and oxygen. Secondly, a series
of redox defense systems can inactivate ROS, which are reduced
glutathione (GSH), NADH, thioredoxin, and free radical
scavengers such as vitamins C and E (Schafer and Buettner, 2001;
Yamamoto et al., 2003; Zima et al., 2004; Gasparetto et al., 2005).
Abnormal NADH accumulation, observed in diabetes, can lead
to reductive stress, pseudohypoxia and subsequent, paradoxical
oxidative stress; interested readers are directed to this article
here (Yan, 2014). Increased oxidative stress is associated with
abnormal function of intracellular organelles such as the ER and
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FIGURE 1 | Signaling mechanisms linking increased reactive oxygen species (ROS) production and ion channel remodeling.
mitochondria (Wong et al., 2013; Cheang et al., 2014; Lenna
et al., 2014; Murugan et al., 2015; Zhang et al., 2015). Since
both the ER and mitochondria are associated with Ca2+ release
and uptake in cardiomyocytes and abnormal Ca2+ handling in
these cells can cause arrhythmias, it is not surprisingly that ED
could be the initial trigger. ROS can also promote structural
and electrophysiological remodeling, leading to abnormalities in
action potential (AP) conduction or repolarization (Tse and Yeo,
2015), and in turn to triggered activity or circus-type reentry
(Figure 2). These mechanisms are considered in further detail
below.
TRIGGERED ACTIVITY AND REENTRY
CAN RESULT FROM ROS GENERATION
Action Potential Prolongation and
Abnormal Ca2+ Handling Can Lead to
Triggered Activity
Triggered activity results from afterdepolarizations, which are
secondary depolarization events arising prematurely before
generation of the next AP (Cranefield, 1977; January et al.,
1991). They can occur before or after full repolarization, termed
early afterdepolarizations (EADs) or delayed afterdepolarizations
(DADs), respectively. EADs typically develop when action
potential durations (APDs) are prolonged, due to a greater
magnitude of inward depolarizing currents (INa, ICa, INCX)
compared to the outward repolarizing currents (IKr, IKs, IK1)
(Tse, 2015). This would enable reactivation of the L-type calcium
channel, thereby increasing ICa,L (January and Riddle, 1989).
By contrast, DADs occur when there is intracellular Ca2+
overload, which induces Ca2+-induced Ca2+ release from the
ER. This activates the sodium-calcium exchange current, INCX,
the nonselective cationic current, INS and the calcium-activated
chloride current, ICl,Ca (Guinamard et al., 2004). The net result
of EAD or DAD is membrane depolarization and initiation of
another AP. If the afterdepolarizations are not sufficiently large
to induce an AP, they can exacerbate the regional differences
in repolarization, which may lead to alternans, unidirectional
conduction block and reentry (Tse et al., in press).
Electrophysiological remodeling is observed in heart failure,
with mostly downregulation of ion channels, leading to APD
prolongation and/or altered calcium release, predisposing to
EADs, DADs, and reentry (Marfella et al., 2013; Tse et al., 2016a).
Moreover, the activities of ion channels may condition heart
failure and arrhythmic state, regulating epigenetic mechanisms
related to cardiac adaptive responses (Sardu et al., 2014c,
2015). The renin-angiotensin system (RAS) becomes activated
in diabetes, hypertension and heart failure. This pathway is
responsible for enzymatic cleavage of angiotensinogen, which is
converted to angiotensin I and angiotensin II (Ang-II) by renin
and angiotensin converting enzyme (ACE), respectively. Ang-II
can activate the AT1 receptor, which increases NADPH oxidase
activity to promote ROS production, resulting in downregulation
of the calcium-independent transient outward K+ channel (Ito)
(Lebeche et al., 2006). ROS can increase the activity of MAPK-
activated protein kinase-1 (p90rsk), which phosphorylates and
decreases the activity of Ito, f, IK, slow and ISS channels (Lu et al.,
2008). ROS can prolongs the late sodium current, INa,L (Ma et al.,
2005; Song Y. et al., 2006).
Moreover, prolonged activation of UPR during ER stress in
heart failure leads to increased oxidative stress, downregulation
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FIGURE 2 | Increased reactive oxygen species (ROS) production in cardio-metabolic disorders induce both conduction and repolarization
abnormalities, thereby leading to both triggered and reentrant arrhythmogenesis. UPR, unfolded protein response; RIRR, ROS-induced ROS release; 19m,
mitochondrial inner membrane potential.
of Ito and increased Ca
2+ release from the SR. RyR2, the cardiac-
specific isoform, is affected by post-translational modification
from intracellular signaling cascades. Thus, they can be oxidized
by ROS or reactive carbonyl species (RCS) (Eager et al., 1997; Xu
et al., 1998; Bidasee et al., 2003), or phosphorylation by protein
kinases such as protein kinase A or Ca2+/calmodulin-dependent
protein kinase II (CAMKII), leading to abnormal gating (Witcher
et al., 1991; Hain et al., 1995; Wehrens et al., 2004). This in
turn leads to reduced amplitude but increased frequency of Ca2+
sparks and increased RyR2 sensitivity to Ca2+ activation (Shao
et al., 2007, 2009). RyR2 decoupling from LTCCs can lead to
desynchronized Ca2+ release (Song L.S. et al., 2006). ROS derived
from the mitochondria could inhibit SERCA and stimulate RyR2,
thereby activating NCX, Ca2+-sensitive cationic channels and
Ca2+-induced Ca2+-release (Li et al., 2015).
Aside from regulation of energy production, mitochondria
can also take up and release Ca2+ through several mechanisms,
and may therefore serve as a buffer system. It may be that under
physiological conditions, mitochondria do not have a major
role in buffering Ca2+ (O’Rourke and Blatter, 2009; Williams
et al., 2013). However, in heart failure, there is significant
Ca2+ overload in both the cytoplasm and the mitochondria of
cardiomyocytes (Santulli et al., 2015b). Experiments in a mouse
model of heart failure generated by myocardial infarction, leaky
RyR2 was shown to be responsible for mitochondrial Ca2+
overload (Santulli et al., 2015b). This would lead tomitochondrial
dysfunction and increased ROS production. A recent study found
that in mice with RyR2 mutations leading to diastolic Ca2+
leak, increased RyR2 oxidation, mitochondrial dysfunction and
increased ROS production are observed, and these findings were
associated with an increase in atrial fibrillation (AF) susceptibility
(Xie et al., 2015a). Other studies also support the critical role of
increased oxidative stress in the development and maintenance
of AF. Thus, ROS from the atria correlated with the duration
and substrate of AF in goats and humans (Reilly et al., 2011).
Increasedmitochondrial oxidative stress leading to RyR2 leak has
also been observed in the ventricles of a peroxisome proliferator-
activated receptor-γ (PPARg) cardiac overexpression mouse
model (Joseph et al., 2016). The net electrophysiological effect
was AP prolongation and development of ectopic activity.
Together, all of the above mechanisms can prolong APD
and/or lead to abnormal Ca2+ release, inducing EADs and DADs
and therefore triggered activity.
Disruption of Normal AP Conduction or
Repolarization and Abnormal Ca2+
Handling Can Lead to Reentry
The conduction of cardiac APs through the workingmyocardium
has traditionally been described by the core conductor model.
This is based on the cable theory, whose equations can be derived
by applying Kirchoff’s circuit law. Conduction velocity (CV) is
determined by both passive and active properties of the cell
membrane. The passive components are axial resistance of the
myoplasm (ri), resistance of the extracellular space (ro), and
membrane capacitance (Cm). Diameter of the cardiomyocyte is
important because it alters both ri and Cm. Active membrane
properties refer to the voltage-gated conductances, mainly the
sodium current (INa) mediating the AP upstroke. This model
was subsequently modified to account for the presence of gap
junctions (Saffitz et al., 1994; Rohr, 2004). Each gap junction
consists of two connexons, which are hexameric proteins of
the connexin (Cx) subunit, mediating electrical communication
by electrotonic spread. However, it forms a high resistance
pathway that can decrease CV and produce discontinuous
propagation (Spach et al., 1981; Spach, 2003). Its expression is
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not equally distributed across the myocardium, higher numbers
are found at the ends of myocytes compared to the lateral
aspects of the cell membrane (Kumar and Gilula, 1996).
Consequently, CV is higher in the longitudinal direction than in
the transverse direction, which is termed anisotropic conduction
(Sano et al., 1959; Clerc, 1976). The role of ephaptic coupling
has been neglected until recently, involving a direct electrical
field mechanism for mediating conduction (Rhett and Gourdie,
2012; Lin and Keener, 2013; Rhett et al., 2013; Veeraraghavan
et al., 2014a,b,c; George et al., 2015; Veeraraghavan et al., 2015).
Finally, myocardial fibrosis cam reduce the coupling between
cardiomyocytes, increasing ri, and enhance the coupling between
fibroblasts and cardiomyocytes (Camelliti et al., 2004; Chilton
et al., 2007), increasing cm, both of which would reduce CV and
increase the dispersion of CV (Tse and Yeo, 2015).
Circus-type reentry occurs when an AP travels around an
obstacle and re-excites its site of origin, and requires both
conduction and repolarization abnormalities (Tse, 2015; Tse et al.,
2016d,h). Firstly, conduction velocity (CV) must be sufficiently
slowed to prevent the AP depolarization wavefront from colliding
with its repolarization wave back, where the local myocardium
is still in its effective refractory period (ERP) and cannot be
excited. If this occurs, conduction will be blocked and the AP will
extinguish, resulting in a break of the reentrant circuit. Secondly,
unidirectional conduction block must be present. Otherwise,
wavefront APs traveling in opposite directions can collide and
extinguish, thereby terminating the arrhythmia. Thirdly, an
obstacle can be a non-conducting or refractory region, arising
from structural defects such as interstitial fibrosis, or dynamically
from ectopic activity. When the excitation wavelength of the AP
wave (λ, CV × ERP) is smaller than the path length, reentry can
occur. The ERP usually coincides with the APD. Thus, reduction
in CV, APD, or ERP can promote reentry by reducing λ, whereas
increased λ reduces the likelihood of reentry (Tse et al., 2012;
Choy et al., 2016; Tse, 2016b; Tse et al., 2016c,e,f,g,h,i,k,l).
All of the above factors are influenced by ROS, altering ion
channel function and promoting extracellular matrix (ECM)
remodeling, which together would produce conduction and
repolarization abnormalities, thereby leading to reentry (Tse and
Yeo, 2015). For example, the SCN5A gene encoding for the
cardiac Na+ channels is regulated by the transcription factor
NF-κB (Shang and Dudley, 2005). Elevated angiotensin II levels
and the increased oxidative stress increase NF-κB binding to the
SCN5A promoter region, thereby decreasing its transcriptional
activity (Shang et al., 2008). Ang-II can also downregulate Cx43
and Cx40, reducing intercellular coupling (Kasi et al., 2007).
During ER stress, PERK activation downregulates the Na+
channels, although this is a non-ion channel specific effect since
Ito expression is also reduced (Gao et al., 2013). Furthermore,
abnormal Ca2+ release can have direct and indirect effects. Ca2+
can bind directly to the evolutionarily conserved EF hand motif
at the carboxyl end of the Na+ channel, thereby producing a
depolarizing shift in its voltage-dependent inactivation, which
prolongs the late sodium current, INa,L (Wingo et al., 2004;
Song Y. et al., 2006). Moreover, the Na+ channel also possesses
an IQ domain for Ca2+/ CaM binding and additionally several
serine/threonine residues amenable to phosphorylation, for
example by CaMKII (Ashpole et al., 2012), leading to channel
inactivation (Tan et al., 2002).
Ca2+ can activate protein kinase C (PKC) (Luo andWeinstein,
1993), which can phosphorylate both Na+ channels (Qu et al.,
1996) and Cx43 (Moreno et al., 1994; Kwak et al., 1995) to reduce
INa and Igap, respectively. Ca
2+ overload is also associated with
dephosphorylation of gap junctions (Huang et al., 1999), leading
to their uncoupling (Beardslee et al., 2000) and lateralization
(Smith et al., 1991; Lampe et al., 2000). Interestingly, a recent
report demonstrated that streptozotocin-induced diabetic mice
have increased phosphorylation levels of Cx43 at the serine 262
residue (Palatinus and Gourdie, 2016). Previous experiments
showed that Ser 262 phosphorylation of Cx43 is associated with
a cardiac injury-resistant state (Srisakuldee et al., 2009). Poor
myocardial healing could increase the likelihood of conduction
abnormalities, which would increase arrhythmogenicity. Finally,
homocysteine, which is raised in hypertension and diabetes,
causes EEC dysfunction and apoptosis (Miller et al., 2000;
Wei et al., 2010), suppression of superoxide dismutase and
activation of matrix metalloproteinases (MMPs) in the plasma
membrane, causing Cx43 disruption (Rosenberger et al., 2006).
Increased Ca2+ leak through the RyR2 channels results in Ca2+
alternans, which in turn can drive APD alternans and reentry
(Xie et al., 2013).
Mitochondrial ROS production is elevated in diabetes and
hypertension (Kakkar et al., 1995; Kanazawa et al., 2002; Dikalov
and Ungvari, 2013). Mitochondrial ROS can itself increase its
own production in a positive feedback loop, termed ROS-induced
ROS release (RIRR), a mechanism recently recognized as a key
initiator of mitochondrial depolarization (Zorov et al., 2000).
Thus, Ang-II can activate the AT1 receptor, which stimulates
Nox2, an enzyme that catalyzes electron transfer fromNADPH to
oxygen, generating oxygen free radicals and hydrogen peroxide.
The oxygen free radical can enter the mitochondria and activate
PKCε at the mitochondrial inner membrane (Jaburek et al.,
2006). The downstream target is mitochondrial KATP channels
(mitoKATP), resulting in reverse electron transfer from complex
II to complex I, which generates more oxygen free radicals
(Dikalov et al., 2014). The latter can be converted to hydrogen
peroxide, activating c-src (Aikawa et al., 1997) and in turn
further activating NADPH oxidases, production of free radicals
and NOS uncoupling. Mitochondrial KATP channel activation
in cardiomyocytes in diabetes led to impaired APD adaptation,
which promoted the occurrence of VT (Xie et al., 2015b). Ang-
II mediated mitochondrial ROS production can lead to c-src
activation and reduced Cx43 expression (Sovari et al., 2013).
Homocysteine can activate mitochondrial MMPs, which leads to
opening the mitochondrial permeability transition pore (MPTP)
(Moshal et al., 2008; Montaigne et al., 2013) and collapse of the
mitochondrial inner membrane potential (19m) (Brown et al.,
2010).
ROS can also activate the mitochondrial inner membrane
anion channels (IMAC) to result in mitochondrial depolarization
(Yang et al., 2010). RIRR-induced regional mitochondrial
depolarization results in the formation of a metabolic sink
(Zhou et al., 2014). Uncoupling of oxidative phosphorylation
can reverse mitochondrial ATP synthase, thereby depleting
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intracellular ATP. This causes sarcolemmal KATP activation,
increased K+ eﬄux and APD shortening (Garlid et al., 1997;
Zhou et al., 2014). Moreover, ROS can promote myocardial
fibrosis via a NOX4-mediated, ROS-ERK1/2-MAP Kinase-
dependent mechanism (Aragno et al., 2006; Kuroda et al.,
2010).
Together, the above factors can lead to reduction in CV,
together with increased repolarization gradients, can promote
unidirectional conduction block and reentry (Tse et al., in press).
ENDOTHELIAL-CARDIOMYOCYTE
COUPLING, PARACRINE SIGNALING, AND
ARRHYTHMOGENESIS
Endothelial cells form the inner lining of blood vessels, thereby
controlling vascular tone by releasing vasodilators, such as
nitric oxide (NO), prostacyclin and endothelial-dependent
hyperpolarizing factor. In the heart, cardiac endothelial cells
(CECs), including myocardial coronary endothelial cells
(MCECs) lining the coronary microvasaculature and endocardial
endothelial cells (EECs), outnumber cardiomyocytes (CM) with
a 3:1 ratio and have roles distinct from those of the vascular
endothelium, such as regulation of cardiomyocyte growth and
modulation of electrical and mechanical functions (Baldwin and
Artman, 1998; Brutsaert, 2003). They may do so in a paracrine
manner by secreting messengers such as NO, prostaglandins,
endothelin and angiotensin II. These may act on specific
receptors on the plasma membrane of cardiomyocytes (e.g.,
Ang-II binding to AT1R), diffuse through the membrane of
cardiomyocytes (in the case of gasotransmitters such as NO), or
enter via gap junctions, to activate their downstream effector.
Gap junctions are non-specific pores that also allows the spread
of molecules up to 1 kDa in molecular mass (Harris, 2001;
Weber et al., 2004). However, MCECs lack gap junctions and
their communication with surrounding cells occur by other
mechanisms.
Endothelial dysfunction is a hallmark of diabetes
mellitus, hypertension and heart disease, playing a role
in the initiation and progression of vascular dysfunction,
eventually resulting in atherosclerosis, thrombosis and
arrhythmogenesis (Wong et al., 2013). This usually refers
to dysfunction of vascular endothelial cells that include
the MCECs. However, EECs also become dysfunctional
in diabetes and hypertension (Chu et al., 1995; Popov
et al., 1996; Brutsaert, 2003). These could initiate signaling
cascades that ultimately modify ion channel function and
promote electrophysiological and structural remodeling in the
myocardium to produce an arrhythmic substrate (Miller et al.,
2002; Rosenberger et al., 2006; Moshal et al., 2008; Givvimani
et al., 2011).
CLINICAL RELEVANCE AND FUTURE
PERSPECTIVES
Reduction in oxidative stress is an attractive strategy
for preventing ROS-induced ion channel dysfunction,
electrophysiological and structural remodeling. In keeping
with this theory, exogenous application of strong reducing
agents such as hydrogen sulfide was shown to reduce cardiac
fibrosis. Increasing the expression of enzymes breaking
down free radicals, such as SOD (Dikalova et al., 2010).
Glutathione peroxidase overexpression in diabetic rat hearts
prevented adverse structural remodeling by reducing fibrosis
and improving diastolic dysfunction (Matsushima et al.,
2006). This would be expected to reduce the degree of
conduction abnormalities and thereby increase the threshold for
arrhythmogenesis.
Much of the cellular oxidative stress is derived from
the mitochondria, which promotes arrhythmogenesis (Xie
et al., 2015a). Therefore, antioxidants specifically targeting
this organelle would be a logical strategy for anti-arrhythmic
therapy. Thus, experiments in genetically modified, ACE8/8
mice with RAS activation have demonstrated therapeutic effects
of a mitochondrial-specific antioxidant, but not a general
antioxidant, in preventing ventricular arrhythmias (Sovari et al.,
2013). Altered mitochondrial bioenergetics characterized by
mitochondrial depolarization is a key initiating factor of an
adverse positive feedback loop of causing RIRR. Interestingly,
inhibition of the MPTP by cyclosporine A did not prevent
the collapse of 19m (Berkich et al., 2003), whereas IMAC
inhibition using the mitochondrial benzodiazepine receptor
did (Akar et al., 2005). Recent work has demonstrated that
patients with catecholaminergic polymorphic VT, in whom
the RyR2 is mutated and leaky, insulin secretion and glucose
metabolism were dysregulated (Santulli et al., 2015a). Since
mitochondrial Ca2+ overload is due to a leaky RyR2 (Santulli
et al., 2015b), ryanodine receptor stabilizers can be used
to reduce this leak and reduce arrhythmic burden (Lehnart
et al., 2006). ER stress is also a potential target, since
a prolonged UPR can induce adverse electrophysiological
remodeling. For example, overexpression of chaperone proteins
Grp78 and Grp94 can increase binding to UPR sensors
and abnormal proteins, in turn alleviating ER and oxidative
stress as well as Ca2+ overload (Vitadello et al., 2003;
Pan et al., 2004).
Many of the above findings have been derived from animal
models, which are amenable to genetic and pharmacological
manipulation (Tse et al., 2012; Chen et al., 2016; Tse et al.,
2016b,c,e,f,g,k, in press). In these systems, electrophysiological
consequences of ion channel mutation or dysfunction can be
examined using different recording methods such as monophasic
action potential or bipolar electrogram recordings, and optical
mapping (Vigmond and Bardakjian, 1995; Vigmond and Leon,
1999; Vigmond, 2005; Vigmond et al., 2009; Tse et al., 2016j).
Furthermore, detection of magnetic signals has been used in
clinical practice: for example magnetic resonance imaging is
excellent for characterization of cardiac structures in humans
but are less practical for use in animal studies (Vassiliou
et al., 2014; Tse et al., 2015a,b). Magnetocardiography (MCG)
can be used to diagnose and predict the risk of cardiac
arrhythmias in humans (Steinhoff et al., 2004; Sato et al.,
2012; Kwong et al., 2013; Ito et al., 2014; Yoshida et al.,
2015). A micromagnetometer array with a superconducting
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quantum interference device (SQUID) can be used for non-
contact recording of MCGs from mice and has the potential
for high-throughput use to screen for pro- or anti-arrhythmic
effects of pharmacological agents (Komamura et al., 2008). Given
the evidence presented here, it is clear that increased ROS
can lead to intracellular organelle dysfunction and arrhythmias
in cardio-metabolic disorders such as diabetes mellitus and
hypertension. It is therefore prudent that the at-risk population
is identified, which would enable early intervention to reduce
arrhythmic mortality (Cardoso et al., 2003; Salles et al., 2005;
Stettler et al., 2007; Clemente et al., 2012; Tse, 2016a,c; Tse and
Yan, 2016a,b).
Nevertheless, because of the complex nature of cardiac
spatiotemporal dynamics, a systems approach is needed to
determine the net effect of a pharmacological agent on
arrhythmogenicity. Identification of the molecular events is
important for developing therapeutic strategies to reduce
oxidative stress, which could slow or even reverse disease
progression of cardio-metabolic disorders, which would in
turn reduce the risk of cardiac arrhythmias complicating these
conditions in this patient population.
AUTHOR CONTRIBUTIONS
GT: Design of manuscript; drafted and critically revised the
manuscript for important intellectual content; preparation of
figures. BY: Interpreted primary research papers; critically revised
the manuscript for important intellectual content. YC: Critically
revised themanuscript for important intellectual content. XT and
YH: Drafted and critically revised the manuscript for important
intellectual content.
ACKNOWLEDGMENTS
GT received a BBSRC Doctoral Training Award, and thanks the
Croucher Foundation of Hong Kong for support of his clinical
assistant professorship.
REFERENCES
Aikawa, R., Komuro, I., Yamazaki, T., Zou, Y., Kudoh, S., Tanaka, M., et al.
(1997). Oxidative stress activates extracellular signal-regulated kinases through
Src and Ras in cultured cardiac myocytes of neonatal rats. J. Clin. Invest. 100,
1813–1821. doi: 10.1172/JCI119709
Akar, F. G., Aon, M. A., Tomaselli, G. F., and O’Rourke, B. (2005). The
mitochondrial origin of postischemic arrhythmias. J. Clin. Invest. 115,
3527–3535. doi: 10.1172/JCI25371
Aragno, M., Mastrocola, R., Medana, C., Catalano, M. G., Vercellinatto, I., Danni,
O., et al. (2006). Oxidative stress-dependent impairment of cardiac-specific
transcription factors in experimental diabetes. Endocrinology 147, 5967–5974.
doi: 10.1210/en.2006-0728
Ashpole, N. M., Herren, A. W., Ginsburg, K. S., Brogan, J. D., Johnson,
D. E., Cummins, T. R., et al. (2012). Ca2+/calmodulin-dependent protein
kinase II (CaMKII) regulates cardiac sodium channel NaV1.5 gating by
multiple phosphorylation sites. J. Biol. Chem. 287, 19856–19869. doi:
10.1074/jbc.M111.322537
Baldwin, H. S., and Artman, M. (1998). Recent advances in cardiovascular
development: promise for the future. Cardiovasc. Res. 40, 456–468. doi:
10.1016/S0008-6363(98)00277-6
Beardslee, M. A., Lerner, D. L., Tadros, P. N., Laing, J. G., Beyer, E. C., Yamada,
K. A., et al. (2000). Dephosphorylation and intracellular redistribution of
ventricular connexin43 during electrical uncoupling induced by ischemia. Circ.
Res. 87, 656–662. doi: 10.1161/01.RES.87.8.656
Berkich, D. A., Salama, G., and LaNoue, K. F. (2003). Mitochondrial membrane
potentials in ischemic hearts. Arch. Biochem. Biophys. 420, 279–286. doi:
10.1016/j.abb.2003.09.021
Bidasee, K. R., Nallani, K., Besch, H. R. Jr., and Dincer, U. D. (2003).
Streptozotocin-induced diabetes increases disulfide bond formation on cardiac
ryanodine receptor (RyR2). J. Pharmacol. Exp. Ther. 305, 989–998. doi:
10.1124/jpet.102.046201
Brand, M. D. (2010). The sites and topology of mitochondrial superoxide
production. Exp. Gerontol. 45, 466–472. doi: 10.1016/j.exger.2010.01.003
Brown, D. A., Aon, M. A., Frasier, C. R., Sloan, R. C., Maloney, A. H., Anderson, E.
J., et al. (2010). Cardiac arrhythmias induced by glutathione oxidation can be
inhibited by preventing mitochondrial depolarization. J. Mol. Cell. Cardiol. 48,
673–679. doi: 10.1016/j.yjmcc.2009.11.011
Brutsaert, D. L. (2003). Cardiac endothelial-myocardial signaling: its role in cardiac
growth, contractile performance, and rhythmicity. Physiol. Rev. 83, 59–115. doi:
10.1152/physrev.00017.2002
Camelliti, P., Green, C. R., LeGrice, I., and Kohl, P. (2004). Fibroblast
network in rabbit sinoatrial node: structural and functional identification of
homogeneous and heterogeneous cell coupling. Circ. Res. 94, 828–835. doi:
10.1161/01.RES.0000122382.19400.14
Cardoso, C. R., Salles, G. F., and Deccache, W. (2003). Prognostic value of QT
interval parameters in type 2 diabetes mellitus: results of a long-term follow-
up prospective study. J. Diabetes Complicat. 17, 169–178. doi: 10.1016/S1056-
8727(02)00206-4
Chan, R. S., and Woo, J. (2010). Prevention of overweight and obesity: how
effective is the current public health approach. Int. J. Environ. Res. Public Health
7, 765–783. doi: 10.3390/ijerph7030765
Chance, B., and Williams, G. R. (1955). Respiratory enzymes in oxidative
phosphorylation. III. The steady state. J. Biol. Chem. 217, 409–427.
Cheang, W. S., Tian, X. Y., Wong, W. T., Lau, C. W., Lee, S. S., Chen, Z. Y.,
et al. (2014). Metformin protects endothelial function in diet-induced obese
mice by inhibition of endoplasmic reticulum stress through 5′ adenosine
monophosphate-activated protein kinase-peroxisome proliferator-activated
receptor delta pathway. Arterioscler. Thromb. Vasc. Biol. 34, 830–836. doi:
10.1161/ATVBAHA.113.301938
Chen, Z., Sun, B., Tse, G., Jiang, J., and Xu, W. (2016). Reversibility of both
sinus node dysfunction and reduced HCN4 mRNA expression level in an
atrial tachycardia pacing model of tachycardia-bradycardia syndrome in rabbit
hearts. Int. J. Clin. Exp. Pathol.
Chilton, L., Giles, W. R., and Smith, G. L. (2007). Evidence of intercellular coupling
between co-cultured adult rabbit ventricular myocytes and myofibroblasts. J.
Physiol. 583, 225–236. doi: 10.1113/jphysiol.2007.135038
Choi, E., Cha, M. J., and Hwang, K. C. (2014). Roles of calcium regulating
MicroRNAs in cardiac ischemia-reperfusion injury. Cells 3, 899–913. doi:
10.3390/cells3030899
Choy, L., Yeo, J. M., Tse, V., Chan, S. P., and Tse, G. (2016). Cardiac disease and
arrhythmogenesis: lessons from mouse studies. Int. J. Cardiol. Heart Vasc. 12,
1–10. doi: 10.1016/j.ijcha.2016.05.005
Chu, G. X., Ling, Q., and Guo, Z. G. (1995). Effects of endocardial endothelium in
myocardial mechanics of hypertrophied myocardium of rats. Zhongguo Yao Li
Xue Bao 16, 352–356.
Clemente, D., Pereira, T., and Ribeiro, S. (2012). Ventricular repolarization in
diabetic patients: characterization and clinical implications. Arq. Bras. Cardiol.
99, 1015–1022. doi: 10.1590/S0066-782X2012005000095
Clerc, L. (1976). Directional differences of impulse spread in trabecular
muscle from mammalian heart. J. Physiol. 255, 335–346. doi:
10.1113/jphysiol.1976.sp011283
Frontiers in Physiology | www.frontiersin.org 7 August 2016 | Volume 7 | Article 313
Tse et al. Increased Oxidative Stress and Cardiac Arrhythmogenesis
Cranefield, P. F. (1977). Action potentials, afterpotentials, and arrhythmias. Circ.
Res. 41, 415–423. doi: 10.1161/01.RES.41.4.415
Dikalov, S. (2011). Cross talk between mitochondria and NADPH oxidases. Free
Radic. Biol. Med. 51, 1289–1301. doi: 10.1016/j.freeradbiomed.2011.06.033
Dikalov, S. I., Nazarewicz, R. R., Bikineyeva, A., Hilenski, L., Lassegue, B.,
Griendling, K. K., et al. (2014). Nox2-induced production of mitochondrial
superoxide in angiotensin II-mediated endothelial oxidative stress and
hypertension. Antioxid. Redox Signal. 20, 281–294. doi: 10.1089/ars.2012.4918
Dikalov, S. I., and Ungvari, Z. (2013). Role of mitochondrial oxidative stress in
hypertension. Am. J. Physiol. Heart Circ. Physiol. 305, H1417–H1427. doi:
10.1152/ajpheart.00089.2013
Dikalova, A. E., Bikineyeva, A. T., Budzyn, K., Nazarewicz, R. R., McCann, L.,
Lewis, W., et al. (2010). Therapeutic targeting of mitochondrial superoxide in
hypertension. Circ. Res. 107, 106–116. doi: 10.1161/CIRCRESAHA.109.214601
Eager, K. R., Roden, L. D., and Dulhunty, A. F. (1997). Actions of sulfhydryl
reagents on single ryanodine receptor Ca(2+)-release channels from sheep
myocardium. Am. J. Physiol. 272, C1908–C1918.
Gao, G., Xie, A., Zhang, J., Herman, A. M., Jeong, E. M., Gu, L., et al.
(2013). Unfolded protein response regulates cardiac sodium current in
systolic human heart failure. Circ. Arrhythm. Electrophysiol. 6, 1018–1024. doi:
10.1161/CIRCEP.113.000274
Garlid, K. D., Paucek, P., Yarov-Yarovoy, V., Murray, H. N., Darbenzio, R.
B., D’Alonzo, A. J., et al. (1997). Cardioprotective effect of diazoxide
and its interaction with mitochondrial ATP-sensitive K+ channels.
Possible mechanism of cardioprotection. Circ. Res. 81, 1072–1082. doi:
10.1161/01.RES.81.6.1072
Gasparetto, C., Malinverno, A., Culacciati, D., Gritti, D., Prosperini, P. G.,
Specchia, G., et al. (2005). Antioxidant vitamins reduce oxidative stress and
ventricular remodeling in patients with acute myocardial infarction. Int. J.
Immunopathol. Pharmacol. 18, 487–496. doi: 10.1177/039463200501800308
George, S. A., Sciuto, K. J., Lin, J., Salama, M. E., Keener, J. P., Gourdie, R.
G., et al. (2015). Extracellular sodium and potassium levels modulate cardiac
conduction in mice heterozygous null for the Connexin43 gene. Pflugers Arch.
467, 2287–2297. doi: 10.1007/s00424-015-1698-0
Givvimani, S., Qipshidze, N., Tyagi, N., Mishra, P. K., Sen, U., and Tyagi, S.
C. (2011). Synergism between arrhythmia and hyperhomo-cysteinemia in
structural heart disease. Int. J. Physiol. Pathophysiol. Pharmacol. 3, 107–119.
Glembotski, C. C. (2012). Roles for the sarco-/endoplasmic reticulum in cardiac
myocyte contraction, protein synthesis, and protein quality control. Physiology
27, 343–350. doi: 10.1152/physiol.00034.2012
Guinamard, R., Chatelier, A., Demion, M., Potreau, D., Patri, S., Rahmati, M.,
et al. (2004). Functional characterization of a Ca(2+)-activated non-selective
cation channel in human atrial cardiomyocytes. J. Physiol. 558, 75–83. doi:
10.1113/jphysiol.2004.063974
Hain, J., Onoue, H., Mayrleitner, M., Fleischer, S., and Schindler, H. (1995).
Phosphorylation modulates the function of the calcium release channel of
sarcoplasmic reticulum from cardiac muscle. J. Biol. Chem. 270, 2074–2081.
doi: 10.1074/jbc.270.5.2074
Harris, A. L. (2001). Emerging issues of connexin channels: biophysics fills the gap.
Q. Rev. Biophys. 34, 325–472. doi: 10.1017/S0033583501003705
Huang, X. D., Sandusky, G. E., and Zipes, D. P. (1999). Heterogeneous loss of
connexin43 protein in ischemic dog hearts. J. Cardiovasc. Electrophysiol. 10,
79–91. doi: 10.1111/j.1540-8167.1999.tb00645.x
Ito, Y., Shiga, K., Yoshida, K., Ogata, K., Kandori, A., Inaba, T., et al. (2014).
Development of a magnetocardiography-based algorithm for discrimination
between ventricular arrhythmias originating from the right ventricular outflow
tract and those originating from the aortic sinus cusp: a pilot study. Heart
Rhythm. 11, 1605–1612. doi: 10.1016/j.hrthm.2014.05.032
Jaburek, M., Costa, A. D., Burton, J. R., Costa, C. L., and Garlid, K. D.
(2006). Mitochondrial PKC epsilon and mitochondrial ATP-sensitive
K+ channel copurify and coreconstitute to form a functioning
signaling module in proteoliposomes. Circ. Res. 99, 878–883. doi:
10.1161/01.RES.0000245106.80628.d3
January, C. T., Chau, V., andMakielski, J. C. (1991). Triggered activity in the heart:
cellular mechanisms of early after-depolarizations. Eur. Heart J. 12, 4–9. doi:
10.1093/eurheartj/12.suppl_F.4
January, C. T., and Riddle, J. M. (1989). Early afterdepolarizations: mechanism of
induction and block. A role for L-type Ca2+ current. Circ. Res. 64, 977–990.
doi: 10.1161/01.RES.64.5.977
Joseph, L. C., Subramanyam, P., Radlicz, C., Trent, C. M., Iyer, V., Colecraft,
H. M., et al. (2016). Mitochondrial oxidative stress during cardiac lipid
overload causes intracellular calcium leak and arrhythmia. Heart Rhythm. doi:
10.1016/j.hrthm.2016.05.002. [Epub ahead of print].
Kakkar, R., Kalra, J., Mantha, S. V., and Prasad, K. (1995). Lipid peroxidation
and activity of antioxidant enzymes in diabetic rats. Mol. Cell. Biochem. 151,
113–119. doi: 10.1007/BF01322333
Kanazawa, A., Nishio, Y., Kashiwagi, A., Inagaki, H., Kikkawa, R., and Horiike, K.
(2002). Reduced activity of mtTFA decreases the transcription in mitochondria
isolated from diabetic rat heart. Am. J. Physiol. Endocrinol. Metab. 282, E778–
E785. doi: 10.1152/ajpendo.00255.2001
Kasi, V. S., Xiao, H. D., Shang, L. L., Iravanian, S., Langberg, J., Witham, E. A.,
et al. (2007). Cardiac-restricted angiotensin-converting enzyme overexpression
causes conduction defects and connexin dysregulation. Am. J. Physiol. Heart
Circ. Physiol. 293, H182–H192. doi: 10.1152/ajpheart.00684.2006
Komamura, K., Adachi, Y., Miyamoto, M., Kawai, J., Haruta, Y., and Uehara,
G. (2008). Micro-Magnetocardiography system with a single-chip SQUID
magnetometer array for QT analysis and diagnosis of myocardial injury
in small animals. IEEE Trans. Biomed. Circuits Syst. 2, 260–268. doi:
10.1109/TBCAS.2008.2003979
Kumar, N. M., and Gilula, N. B. (1996). The gap junction communication channel.
Cell 84, 381–388. doi: 10.1016/S0092-8674(00)81282-9
Kuroda, J., Ago, T., Matsushima, S., Zhai, P., Schneider, M. D., and Sadoshima,
J. (2010). NADPH oxidase 4 (Nox4) is a major source of oxidative stress
in the failing heart. Proc. Natl. Acad. Sci. U.S.A. 107, 15565–15570. doi:
10.1073/pnas.1002178107
Kwak, B. R., Hermans, M.M., De Jonge, H. R., Lohmann, S. M., Jongsma, H. J., and
Chanson, M. (1995). Differential regulation of distinct types of gap junction
channels by similar phosphorylating conditions. Mol. Biol. Cell 6, 1707–1719.
doi: 10.1091/mbc.6.12.1707
Kwong, J. S., Leithauser, B., Park, J. W., and Yu, C. M. (2013). Diagnostic
value of magnetocardiography in coronary artery disease and cardiac
arrhythmias: a review of clinical data. Int. J. Cardiol. 167, 1835–1842. doi:
10.1016/j.ijcard.2012.12.056
Lampe, P. D., TenBroek, E. M., Burt, J. M., Kurata, W. E., Johnson, R. G., and Lau,
A. F. (2000). Phosphorylation of connexin43 on serine368 by protein kinase
C regulates gap junctional communication. J. Cell Biol. 149, 1503–1512. doi:
10.1083/jcb.149.7.1503
Lebeche, D., Kaprielian, R., and Hajjar, R. (2006). Modulation of action potential
duration on myocyte hypertrophic pathways. J. Mol. Cell. Cardiol. 40, 725–735.
doi: 10.1016/j.yjmcc.2006.01.018
Lehnart, S. E., Terrenoire, C., Reiken, S., Wehrens, X. H. T., Song, L.-S., Tillman, E.
J., et al. (2006). Stabilization of cardiac ryanodine receptor prevents intracellular
calcium leak and arrhythmias. Proc. Natl. Acad. Sci. U.S.A. 103, 7906–7910. doi:
10.1073/pnas.0602133103
Lenna, S., Han, R., and Trojanowska, M. (2014). Endoplasmic reticulum stress and
endothelial dysfunction. IUBMB Life 66, 530–537. doi: 10.1002/iub.1292
Li, Q., Su, D., O’Rourke, B., Pogwizd, S. M., and Zhou, L. (2015). Mitochondria-
derived ROS bursts disturb Ca2+ cycling and induce abnormal automaticity
in guinea pig cardiomyocytes: a theoretical study. Am. J. Physiol. Heart Circ.
Physiol. 308, H623–H636. doi: 10.1152/ajpheart.00493.2014
Lin, J., and Keener, J. P. (2013). Ephaptic coupling in cardiac myocytes. IEEE Trans.
Biomed. Eng. 60, 576–582. doi: 10.1109/TBME.2012.2226720
Lu, Z., Abe, J., Taunton, J., Lu, Y., Shishido, T., McClain, C., et al. (2008). Reactive
oxygen species-induced activation of p90 ribosomal S6 kinase prolongs cardiac
repolarization through inhibiting outward K+ channel activity. Circ. Res. 103,
269–278. doi: 10.1161/CIRCRESAHA.107.166678
Luo, J. H., and Weinstein, I. B. (1993). Calcium-dependent activation of protein
kinase C. The role of the C2 domain in divalent cation selectivity. J. Biol. Chem.
268, 23580–23584.
Ma, J. H., Luo, A. T., and Zhang, P. H. (2005). Effect of hydrogen peroxide on
persistent sodium current in guinea pig ventricular myocytes. Acta Pharmacol.
Sin. 26, 828–834. doi: 10.1111/j.1745-7254.2005.00154.x
Frontiers in Physiology | www.frontiersin.org 8 August 2016 | Volume 7 | Article 313
Tse et al. Increased Oxidative Stress and Cardiac Arrhythmogenesis
Marfella, R., Di Filippo, C., Potenza, N., Sardu, C., Rizzo, M. R., Siniscalchi, M.,
et al. (2013). Circulating microRNA changes in heart failure patients treated
with cardiac resynchronization therapy: responders vs. non-responders. Eur. J.
Heart Fail. 15, 1277–1288. doi: 10.1093/eurjhf/hft088
Matsushima, S., Kinugawa, S., Ide, T., Matsusaka, H., Inoue, N., Ohta, Y.,
et al. (2006). Overexpression of glutathione peroxidase attenuates myocardial
remodeling and preserves diastolic function in diabetic heart. Am. J. Physiol.
Heart Circ. Physiol. 291, H2237–H2245. doi: 10.1152/ajpheart.00427.2006
Miller, A., Mujumdar, V., Palmer, L., Bower, J. D., and Tyagi, S. C. (2002). Reversal
of endocardial endothelial dysfunction by folic acid in homocysteinemic
hypertensive rats. Am. J. Hypertens. 15, 157–163. doi: 10.1016/S0895-
7061(01)02286-5
Miller, A., Mujumdar, V., Shek, E., Guillot, J., Angelo, M., Palmer, L., et al.
(2000). Hyperhomocyst(e)inemia induces multiorgan damage. Heart Vessels
15, 135–143. doi: 10.1007/s003800070030
Montaigne, D., Marechal, X., Lefebvre, P., Modine, T., Fayad, G., Dehondt, H.,
et al. (2013). Mitochondrial dysfunction as an arrhythmogenic substrate: a
translational proof-of-concept study in patients with metabolic syndrome in
whom post-operative atrial fibrillation develops. J. Am. Coll. Cardiol. 62,
1466–1473. doi: 10.1016/j.jacc.2013.03.061
Moreno, A. P., Saez, J. C., Fishman, G. I., and Spray, D. C. (1994). Human
connexin43 gap junction channels. Regulation of unitary conductances by
phosphorylation. Circ. Res. 74, 1050–1057. doi: 10.1161/01.RES.74.6.1050
Moshal, K. S., Metreveli, N., Frank, I., and Tyagi, S. C. (2008). Mitochondrial MMP
activation, dysfunction and arrhythmogenesis in hyperhomocysteinemia. Curr.
Vasc. Pharmacol. 6, 84–92. doi: 10.2174/157016108783955301
Murugan, D., Lau, Y. S., Lau, W. C., Mustafa, M. R., and Huang, Y.
(2015). Angiotensin 1-7 protects against angiotensin II-induced endoplasmic
reticulum stress and endothelial dysfunction via mas receptor. PLoS ONE
10:e0145413. doi: 10.1371/journal.pone.0145413
Nazarewicz, R. R., Dikalova, A. E., Bikineyeva, A., and Dikalov, S. I. (2013). Nox2
as a potential target of mitochondrial superoxide and its role in endothelial
oxidative stress. Am. J. Physiol. Heart Circ. Physiol. 305, H1131–H1140. doi:
10.1152/ajpheart.00063.2013
O’Rourke, B., and Blatter, L. A. (2009). Mitochondrial Ca2+ uptake: tortoise or
hare? J. Mol. Cell. Cardiol. 46, 767–774. doi: 10.1016/j.yjmcc.2008.12.011
Palatinus, J. A., and Gourdie, R. G. (2016). Diabetes increases cryoinjury size
with associated effects on Cx43 gap junction function and phosphorylation
in the mouse heart. J. Diabetes Res. 2016:8789617. doi: 10.1155/2016/
8789617
Pan, Y. X., Lin, L., Ren, A. J., Pan, X. J., Chen, H., Tang, C. S., et al. (2004).
HSP70 and GRP78 induced by endothelin-1 pretreatment enhance tolerance
to hypoxia in cultured neonatal rat cardiomyocytes. J. Cardiovasc. Pharmacol.
44(Suppl. 1), S117–S120. doi: 10.1097/01.fjc.0000166234.11336.a9
Panov, A., Dikalov, S., Shalbuyeva, N., Hemendinger, R., Greenamyre, J. T.,
and Rosenfeld, J. (2007). Species- and tissue-specific relationships between
mitochondrial permeability transition and generation of ROS in brain and liver
mitochondria of rats and mice. Am. J. Physiol. Cell Physiol. 292, C708–C718.
doi: 10.1152/ajpcell.00202.2006
Popov, D., Sima, A., Stern, D., and Simionescu, M. (1996). The
pathomorphological alterations of endocardial endothelium in experimental
diabetes and diabetes associated with hyperlipidemia. Acta Diabetol. 33, 41–47.
doi: 10.1007/BF00571939
Qu, Y., Rogers, J. C., Tanada, T. N., Catterall, W. A., and Scheuer, T. (1996).
Phosphorylation of S1505 in the cardiac Na+ channel inactivation gate is
required for modulation by protein kinase C. J. Gen. Physiol. 108, 375–379. doi:
10.1085/jgp.108.5.375
Reilly, S. N., Jayaram, R., Nahar, K., Antoniades, C., Verheule, S., Channon,
K. M., et al. (2011). Atrial sources of reactive oxygen species vary
with the duration and substrate of atrial fibrillation: implications for
the antiarrhythmic effect of statins. Circulation 124, 1107–1117. doi:
10.1161/CIRCULATIONAHA.111.029223
Rhett, J. M., and Gourdie, R. G. (2012). The perinexus: a new feature
of Cx43 gap junction organization. Heart Rhythm. 9, 619–623. doi:
10.1016/j.hrthm.2011.10.003
Rhett, J. M., Veeraraghavan, R., Poelzing, S., and Gourdie, R. G. (2013). The
perinexus: sign-post on the path to a new model of cardiac conduction? Trends
Cardiovasc. Med. 23, 222–228. doi: 10.1016/j.tcm.2012.12.005
Rohr, S. (2004). Role of gap junctions in the propagation of the cardiac action
potential. Cardiovasc. Res. 62, 309–322. doi: 10.1016/j.cardiores.2003.11.035
Rosenberger, D., Moshal, K. S., Kartha, G. K., Tyagi, N., Sen, U., Lominadze,
D., et al. (2006). Arrhythmia and neuronal/endothelial myocyte uncoupling
in hyperhomocysteinemia. Arch. Physiol. Biochem. 112, 219–227. doi:
10.1080/13813450601093443
Saffitz, J. E., Kanter, H. L., Green, K. G., Tolley, T. K., and Beyer, E. C.
(1994). Tissue-specific determinants of anisotropic conduction velocity in
canine atrial and ventricular myocardium. Circ. Res. 74, 1065–1070. doi:
10.1161/01.RES.74.6.1065
Salles, G. F., Deccache, W., and Cardoso, C. R. (2005). Usefulness of QT-
interval parameters for cardiovascular risk stratification in type 2 diabetic
patients with arterial hypertension. J. Hum. Hypertens. 19, 241–249. doi:
10.1038/sj.jhh.1001815
Sano, T., Takayama, N., and Shimamoto, T. (1959). Directional difference
of conduction velocity in the cardiac ventricular syncytium studied by
microelectrodes. Circ. Res. 7, 262–267. doi: 10.1161/01.RES.7.2.262
Santulli, G., Pagano, G., Sardu, C., Xie, W., Reiken, S., D’Ascia, S. L., et al.
(2015a). Calcium release channel RyR2 regulates insulin release and glucose
homeostasis. J. Clin. Invest. 125, 1968–1978. doi: 10.1172/JCI79273
Santulli, G., Xie, W., Reiken, S. R., and Marks, A. R. (2015b). Mitochondrial
calcium overload is a key determinant in heart failure. Proc. Natl. Acad. Sci.
U.S.A. 112, 11389–11394. doi: 10.1073/pnas.1513047112
Sardu, C., Barbieri, M., Rizzo, M. R., Paolisso, P., Paolisso, G., and Marfella,
R. (2016). Cardiac resynchronization therapy outcomes in type 2 diabetic
patients: role of microRNA changes. J. Diabetes Res. 2016:7292564. doi:
10.1155/2016/7292564
Sardu, C., Carreras, G., Katsanos, S., Kamperidis, V., Pace, M. C., Passavanti, M. B.,
et al. (2014a).Metabolic syndrome is associated with a poor outcome in patients
affected by outflow tract premature ventricular contractions treated by catheter
ablation. BMC Cardiovasc. Disord. 14:176. doi: 10.1186/1471-2261-14-176
Sardu, C., Marfella, R., and Santulli, G. (2014b). Impact of diabetes mellitus on
the clinical response to cardiac resynchronization therapy in elderly people. J.
Cardiovasc. Transl. Res. 7, 362–368. doi: 10.1007/s12265-014-9545-9
Sardu, C., Marfella, R., Santulli, G., and Paolisso, G. (2014c). Functional role
of miRNA in cardiac resynchronization therapy. Pharmacogenomics 15,
1159–1168. doi: 10.2217/pgs.14.76
Sardu, C., Santamaria, M., Paolisso, G., and Marfella, R. (2015). microRNA
expression changes after atrial fibrillation catheter ablation. Pharmacogenomics
16, 1863–1877. doi: 10.2217/pgs.15.117
Sato, Y., Yoshida, K., Ogata, K., Inaba, T., Tada, H., Sekiguchi, Y., et al. (2012). An
increase in right atrial magnetic strength is a novel predictor of recurrence of
atrial fibrillation after radiofrequency catheter ablation. Circ. J. 76, 1601–1608.
doi: 10.1253/circj.CJ-11-1419
Schafer, F. Q., and Buettner, G. R. (2001). Redox environment of the cell as viewed
through the redox state of the glutathione disulfide/glutathione couple. Free
Radic. Biol. Med. 30, 1191–1212. doi: 10.1016/S0891-5849(01)00480-4
Shang, L. L., and Dudley, S. C. Jr. (2005). Tandem promoters and developmentally
regulated 5′- and 3′-mRNA untranslated regions of the mouse Scn5a cardiac
sodium channel. J. Biol. Chem. 280, 933–940. doi: 10.1074/jbc.M409977200
Shang, L. L., Sanyal, S., Pfahnl, A. E., Jiao, Z., Allen, J., Liu, H., and Dudley, S. C. Jr.
(2008). NF-kappaB-dependent transcriptional regulation of the cardiac scn5a
sodium channel by angiotensin II. Am. J. Physiol. Cell Physiol. 294, C372–C379.
doi: 10.1152/ajpcell.00186.2007
Shao, C. H., Rozanski, G. J., Patel, K. P., and Bidasee, K. R. (2007). Dyssynchronous
(non-uniform) Ca2+ release inmyocytes from streptozotocin-induced diabetic
rats. J. Mol. Cell Cardiol. 42, 234–246. doi: 10.1016/j.yjmcc.2006.08.018
Shao, C.-H., Wehrens, X. H. T., Wyatt, T. A., Parbhu, S., Rozanski, G. J.,
Patel, K. P., et al. (2009). Exercise training during diabetes attenuates cardiac
ryanodine receptor dysregulation. J. Appl. Physiol. 106, 1280–1292. doi:
10.1152/japplphysiol.91280.2008
Smith, J. H., Green, C. R., Peters, N. S., Rothery, S., and Severs, N. J. (1991).
Altered patterns of gap junction distribution in ischemic heart disease. An
immunohistochemical study of human myocardium using laser scanning
confocal microscopy. Am. J. Pathol. 139, 801–821.
Song, L. S., Sobie, E. A., McCulle, S., Lederer, W. J., Balke, C. W., and Cheng, H.
(2006). Orphaned ryanodine receptors in the failing heart. Proc. Natl. Acad. Sci.
U.S.A. 103, 4305–4310. doi: 10.1073/pnas.0509324103
Frontiers in Physiology | www.frontiersin.org 9 August 2016 | Volume 7 | Article 313
Tse et al. Increased Oxidative Stress and Cardiac Arrhythmogenesis
Song, Y., Shryock, J. C., Wagner, S., Maier, L. S., and Belardinelli, L.
(2006). Blocking late sodium current reduces hydrogen peroxide-induced
arrhythmogenic activity and contractile dysfunction. J. Pharmacol. Exp. Ther.
318, 214–222. doi: 10.1124/jpet.106.101832
Sovari, A. A., Rutledge, C. A., Jeong, E. M., Dolmatova, E., Arasu, D., Liu,
H., et al. (2013). Mitochondria oxidative stress, connexin43 remodeling, and
sudden arrhythmic death. Circ. Arrhythm. Electrophysiol. 6, 623–631. doi:
10.1161/CIRCEP.112.976787
Spach, M. S. (2003). Transition from a continuous to discontinuous
understanding of cardiac conduction. Circ. Res. 92, 125–126. doi:
10.1161/01.RES.0000056973.54305.67
Spach, M. S., Miller, W. T. III., Geselowitz, D. B., Barr, R. C., Kootsey, J.
M., and Johnson, E. A. (1981). The discontinuous nature of propagation
in normal canine cardiac muscle. Evidence for recurrent discontinuities of
intracellular resistance that affect the membrane currents. Circ. Res. 48, 39–54.
doi: 10.1161/01.RES.48.1.39
Srisakuldee, W., Jeyaraman, M. M., Nickel, B. E., Tanguy, S., Jiang, Z. S.,
and Kardami, E. (2009). Phosphorylation of connexin-43 at serine 262
promotes a cardiac injury-resistant state. Cardiovasc. Res. 83, 672–681. doi:
10.1093/cvr/cvp142
Starkov, A. A., Fiskum, G., Chinopoulos, C., Lorenzo, B. J., Browne, S. E.,
Patel, M. S., et al. (2004). Mitochondrial alpha-ketoglutarate dehydrogenase
complex generates reactive oxygen species. J. Neurosci. 24, 7779–7788. doi:
10.1523/JNEUROSCI.1899-04.2004
Steinhoff, U., Knappe-Grueneberg, S., Schnabel, A., Trahms, L., Smith, F.,
Langley, P., et al. (2004). Magnetocardiography for pharmacology safety studies
requiring high patient throughput and reliability. J. Electrocardiol. 37(Suppl.),
187–192. doi: 10.1016/j.jelectrocard.2004.08.055
Stettler, C., Bearth, A., Allemann, S., Zwahlen, M., Zanchin, L., Deplazes, M., et al.
(2007). QTc interval and resting heart rate as long-term predictors of mortality
in type 1 and type 2 diabetes mellitus: a 23-year follow-up. Diabetologia 50,
186–194. doi: 10.1007/s00125-006-0483-1
St-Pierre, J., Buckingham, J. A., Roebuck, S. J., and Brand, M. D. (2002). Topology
of superoxide production from different sites in the mitochondrial electron
transport chain. J. Biol. Chem. 277, 44784–44790. doi: 10.1074/jbc.M207217200
Tahara, E. B., Navarete, F. D., and Kowaltowski, A. J. (2009). Tissue-
, substrate-, and site-specific characteristics of mitochondrial reactive
oxygen species generation. Free Radic. Biol. Med. 46, 1283–1297. doi:
10.1016/j.freeradbiomed.2009.02.008
Tan, H. L., Kupershmidt, S., Zhang, R., Stepanovic, S., Roden, D. M., Wilde, A.
A., et al. (2002). A calcium sensor in the sodium channel modulates cardiac
excitability. Nature 415, 442–447. doi: 10.1038/415442a
Tsang, K. Y., Chan, D., Bateman, J. F., and Cheah, K. S. (2010). In vivo cellular
adaptation to ER stress: survival strategies with double-edged consequences. J.
Cell Sci. 123, 2145–2154. doi: 10.1242/jcs.068833
Tse, G. (2015). Mechanisms of cardiac arrhythmias. J. Arrhythm. 32, 75–81. doi:
10.1016/j.joa.2015.11.003
Tse, G. (2016a). Both transmural dispersion of repolarization and transmural
dispersion of refractoriness are poor predictors of arrhythmogenicity: a role
for the index of cardiac electrophysiological balance (QT/QRS)? J. Geriatr.
Cardiol.
Tse, G. (2016b). Novel indices for stratifying arrhythmic risk: (Tpeak-Tend)/QRS
and (Tpeak-Tend)/(QT x QRS). J. Geriatr. Cardiol.
Tse, G. (2016c). (Tpeak-Tend)/QRS and (Tpeak-Tend)/(QT x QRS): novel
markers for predicting arrhythmic risk in Brugada syndrome. Europace. doi:
10.17863/CAM.113
Tse, G., Ali, A., Alpendurada, F., Prasad, S., Raphael, C. E., and Vassiliou, V.
(2015a). Tuberculous constrictive pericarditis. Res. Cardiovasc. Med. 4:e29614.
doi: 10.5812/cardiovascmed.29614
Tse, G., Ali, A., Prasad, S. K., Vassiliou, V., and Raphael, C. E. (2015b).
Atypical case of post-partum cardiomyopathy: an overlap syndrome with
arrhythmogenic right ventricular cardiomyopathy? BJR|Case Rep. 1:20150182.
doi: 10.1259/bjrcr.20150182
Tse, G., Hothi, S. S., Grace, A. A., and Huang, C. L. (2012). Ventricular
arrhythmogenesis following slowed conduction in heptanol-treated,
Langendorff-perfused mouse hearts. J. Physiol. Sci. 62, 79–92. doi:
10.1007/s12576-011-0187-2
Tse, G., Lai, E. T., Lee, A. P., Yan, B. P., and Wong, S. H. (2016a).
Electrophysiological mechanisms of gastrointestinal arrhythmogenesis: lessons
from the heart. Front. Physiol. 7:230. doi: 10.3389/fphys.2016.00230
Tse, G., Lai, E. T., Tse, V., and Yeo, J. M. (in press). Molecular and
electrophysiological mechanisms underlying cardiac arrhythmogenesis in
diabetes mellitus. J. Diabetes Res.
Tse, G., Lai, E. T., Yeo, J. M., and Yan, B. P. (2016b). Electrophysiological
mechanisms of Bayés syndrome: insights from clinical and mouse studies.
Front. Physiol. 7:188. doi: 10.3389/fphys.2016.00188
Tse, G., Lai, E. T., Yeo, J.M., and Yan, B. P. (2016c).What is the arrhythmic substrate
in viral myocarditis? Insights from clinical and animal studies. Front. Physiol.
7:308. doi: 10.3389/fphys.2016.00308
Tse, G., Lai, T. H., Yeo, J. M., Tse, V., and Wong, S. H. (2016d). Mechanisms of
electrical activation and conduction in the gastrointestinal system: lessons from
cardiac electrophysiology. Front. Physiol. 7:182. doi: 10.3389/fphys.2016.00182
Tse, G., Sun, B., Wong, S. T., Tse, V., and Yeo, J. M. (2016e). Ventricular anti-
arrhythmic effects of hypercalcaemia treatment in hyperkalaemic, Langendorff-
perfused mouse hearts. Biomed. Rep. doi: 10.3892/br.2016.577
Tse, G., Tse, V., and Yeo, J. M. (2016f). Ventricular anti arrhythmic effects of
heptanol in hypokalaemic, Langendorff perfused mouse hearts. Biomed. Rep.
4, 313–324. doi: 10.3892/br.2016.577
Tse, G., Tse, V., Yeo, J. M., and Sun, B. (2016g). Atrial anti-arrhythmic effects of
heptanol in Langendorff-perfused mouse hearts. PLoS ONE 11:e0148858. doi:
10.1371/journal.pone.0148858
Tse, G., Wong, S. T., Tse, V., Lee, Y. T., Lin, H. Y., and Yeo, J. M.
(in press). Cardiac dynamics: alternans and arrhythmogenesis. J Arrhythm. doi:
10.1016/j.joa.2016.02.009
Tse, G., Wong, S. T., Tse, V., and Yeo, J. M. (2016h). Depolarization vs.
repolarization: what is the mechanism of ventricular arrhythmogenesis
underlying sodium channel haploinsufficiency in mouse hearts? Acta Physiol.
(Oxf). doi: 10.1111/apha.12694. [Epub ahead of print].
Tse, G., Wong, S. T., Tse, V., and Yeo, J. M. (2016i). Determination of action
potential wavelength restitution in Scn5a+/− mouse hearts modelling human
Brugada syndrome. J. Physiol.
Tse, G., Wong, S. T., Tse, V., and Yeo, J. M. (2016j). Monophasic action potential
recordings: which is the recording electrode? J. Basic Clin. Physiol. Pharmacol.
doi: 10.1515/jbcpp-2016-0007. [Epub ahead of print].
Tse, G., Wong, S. T., Tse, V., and Yeo, J. M. (2016k). Restitution analysis of
alternans using dynamic pacing and its comparison with S1S2 restitution in
heptanol-treated, hypokalaemic Langendorff-perfused mouse hearts. Biomed.
Rep. 4, 673–680. doi: 10.3892/br.2016.659
Tse, G., and Yan, B. P. (2016a). Novel arrhythmic risk markers incorporating QRS
dispersion: QRSd x (Tpeak-Tend) / QRS and QRSd x (Tpeak-Tend) / (QT x
QRS). Ann. Noninvasive Electrocardiol.
Tse, G., and Yan, B. P. (2016b). Traditional and novel electrocardiographic markers
for predicting arrhythmic risk and sudden cardiac death. Europace.
Tse, G., and Yeo, J. M. (2015). Conduction abnormalities and ventricular
arrhythmogenesis: the roles of sodium channels and gap junctions. Int. J.
Cardiol. Heart Vasc. 9, 75–82. doi: 10.1016/j.ijcha.2015.10.003
Tse, G., Yeo, J. M., Tse, V., and Sun, B. (2016l). Gap junction inhibition by
heptanol increases ventricular arrhythmogenicity by decreasing conduction
velocity without affecting repolarization properties ormyocardial refractoriness
in Langendorff-perfused mouse hearts.Mol. Med. Rep.
Vassiliou, V., Chin, C., Perperoglou, A., Tse, G., Ali, A., Raphael, C., et al.
(2014). 93 Ejection fraction by cardiovascular magnetic resonance predicts
adverse outcomes post aortic valve replacement. Heart 100, A53–A54. doi:
10.1136/heartjnl-2014-306118.93
Veeraraghavan, R., Lin, J., Hoeker, G. S., Keener, J. P., Gourdie, R. G., and Poelzing,
S. (2015). Sodium channels in the Cx43 gap junction perinexus may constitute
a cardiac ephapse: an experimental and modeling study. Pflugers Arch. 467,
2093–2105. doi: 10.1007/s00424-014-1675-z
Veeraraghavan, R., Poelzing, S., and Gourdie, R. G. (2014a). Intercellular electrical
communication in the heart: a new, active role for the intercalated disk. Cell
Commun. Adhes. 21, 161–167. doi: 10.3109/15419061.2014.905932
Veeraraghavan, R., Poelzing, S., and Gourdie, R. G. (2014b). Novel ligands
for zipping and unzipping the intercalated disk: today’s experimental tools,
tomorrow’s therapies? Cardiovasc. Res. 104, 229–230. doi: 10.1093/cvr/cvu216
Frontiers in Physiology | www.frontiersin.org 10 August 2016 | Volume 7 | Article 313
Tse et al. Increased Oxidative Stress and Cardiac Arrhythmogenesis
Veeraraghavan, R., Poelzing, S., and Gourdie, R. G. (2014c). Old cogs, new tricks:
a scaffolding role for connexin43 and a junctional role for sodium channels?
FEBS Lett. 588, 1244–1248. doi: 10.1016/j.febslet.2014.01.026
Vigmond, E. J. (2005). The electrophysiological basis of MAP recordings.
Cardiovasc. Res. 68, 502–503. doi: 10.1016/j.cardiores.2005.07.020
Vigmond, E. J., and Bardakjian, B. L. (1995). The effect of morphological
interdigitation on field coupling between smooth muscle cells. IEEE Trans.
Biomed. Eng. 42, 162–171. doi: 10.1109/10.341829
Vigmond, E. J., and Leon, L. J. (1999). Electrophysiological basis of mono-
phasic action potential recordings. Med. Biol. Eng. Comput. 37, 359–365. doi:
10.1007/BF02513313
Vigmond, E. J., Tsoi, V., Yin, Y., Page, P., and Vinet, A. (2009). Estimating atrial
action potential duration from electrograms. IEEE Trans. Biomed. Eng. 56,
1546–1555. doi: 10.1109/TBME.2009.2014740
Vitadello, M., Penzo, D., Petronilli, V., Michieli, G., Gomirato, S., Menabo, R.,
et al. (2003). Overexpression of the stress protein Grp94 reduces cardiomyocyte
necrosis due to calcium overload and simulated ischemia. FASEB J. 17, 923–925.
doi: 10.1096/fj.02-0644fje
Weber, P. A., Chang, H.-C., Spaeth, K. E., Nitsche, J. M., and Nicholson, B. J.
(2004). The permeability of gap junction channels to probes of different size
is dependent on connexin composition and permeant-pore affinities. Biophys.
J. 87, 958–973. doi: 10.1529/biophysj.103.036350
Wehrens, X. H., Lehnart, S. E., Reiken, S. R., and Marks, A. R. (2004).
Ca2+/calmodulin-dependent protein kinase II phosphorylation
regulates the cardiac ryanodine receptor. Circ. Res. 94, e61–e70. doi:
10.1161/01.RES.0000125626.33738.E2
Wei, H., Zhang, R., Jin, H., Liu, D., Tang, X., Tang, C., et al. (2010).
Hydrogen sulfide attenuates hyperhomocysteinemia-induced cardiomyocytic
endoplasmic reticulum stress in rats. Antioxid. Redox Signal. 12, 1079–1091.
doi: 10.1089/ars.2009.2898
Williams, G. S., Boyman, L., Chikando, A. C., Khairallah, R. J., and Lederer, W.
J. (2013). Mitochondrial calcium uptake. Proc. Natl. Acad. Sci. U.S.A. 110,
10479–10486. doi: 10.1073/pnas.1300410110
Wingo, T. L., Shah, V. N., Anderson, M. E., Lybrand, T. P., Chazin, W. J., and
Balser, J. R. (2004). An EF-hand in the sodium channel couples intracellular
calcium to cardiac excitability. Nat. Struct. Mol. Biol. 11, 219–225. doi:
10.1038/nsmb737
Witcher, D. R., Kovacs, R. J., Schulman, H., Cefali, D. C., and Jones, L. R. (1991).
Unique phosphorylation site on the cardiac ryanodine receptor regulates
calcium channel activity. J. Biol. Chem. 266, 11144–11152.
Wong, E. L., Woo, J., Hui, E., Chan, C., Chan, W. L., and Cheung, A. W. (2011).
Primary care for diabetes mellitus: perspective from older patients. Patient
Prefer. Adherence 5, 491–498. doi: 10.2147/PPA.S18687
Wong, W. T., Tian, X. Y., and Huang, Y. (2013). Endothelial dysfunction in
diabetes and hypertension: cross talk in RAS, BMP4, and ROS-dependent
COX-2-derived prostanoids. J. Cardiovasc. Pharmacol. 61, 204–214. doi:
10.1097/FJC.0b013e31827fe46e
Xie, W., Santulli, G., Guo, X., Gao, M., Chen, B. X., and Marks, A. R. (2013).
Imaging atrial arrhythmic intracellular calcium in intact heart. J. Mol. Cell
Cardiol. 64, 120–123. doi: 10.1016/j.yjmcc.2013.09.003
Xie, W., Santulli, G., Reiken, S. R., Yuan, Q., Osborne, B. W., Chen, B.-X., et al.
(2015a). Mitochondrial oxidative stress promotes atrial fibrillation. Sci. Rep.
5:11427. doi: 10.1038/srep11427
Xie, Y., Liao, Z., Grandi, E., Shiferaw, Y., and Bers, D. M. (2015b). Slow
[Na]i changes and positive feedback between membrane potential and
[Ca]i underlie intermittent early after depolarizations and arrhythmias.
Circ. Arrhythm. Electrophysiol. 8, 1472–1480. doi: 10.1161/CIRCEP.115.
003085
Xu, L., Eu, J. P., Meissner, G., and Stamler, J. S. (1998). Activation of the cardiac
calcium release channel (ryanodine receptor) by poly-S-nitrosylation. Science
279, 234–237. doi: 10.1126/science.279.5348.234
Yamamoto, M., Yang, G., Hong, C., Liu, J., Holle, E., Yu, X., et al. (2003).
Inhibition of endogenous thioredoxin in the heart increases oxidative stress
and cardiac hypertrophy. J. Clin. Invest. 112, 1395–1406. doi: 10.1172/JCI2003
17700
Yan, L.-J. (2014). Pathogenesis of chronic hyperglycemia: from reductive stress to
oxidative stress. J. Diabetes Res. 2014, 11. doi: 10.1155/2014/137919
Yang, L., Korge, P., Weiss, J. N., and Qu, Z. (2010). Mitochondrial oscillations and
waves in cardiac myocytes: insights from computational models. Biophys. J. 98,
1428–1438. doi: 10.1016/j.bpj.2009.12.4300
Yoshida, K., Ogata, K., Inaba, T., Nakazawa, Y., Ito, Y., Yamaguchi, I., et al. (2015).
Ability of magnetocardiography to detect regional dominant frequencies
of atrial fibrillation. J. Arrhythm. 31, 345–351. doi: 10.1016/j.joa.2015.
05.003
Zhang, Y., Liu, J., Luo, J. Y., Tian, X. Y., Cheang, W. S., Xu, J., et al. (2015).
Upregulation of angiotensin (1-7)-mediated signaling preserves endothelial
function through reducing oxidative stress in diabetes. Antioxid. Redox Signal.
23, 880–892. doi: 10.1089/ars.2014.6070
Zhou, L., Solhjoo, S., Millare, B., Plank, G., Abraham, M. R., Cortassa,
S., et al. (2014). Effects of regional mitochondrial depolarization on
electrical propagation: implications for arrhythmogenesis. Circ. Arrhythm.
Electrophysiol. 7, 143–151. doi: 10.1161/CIRCEP.113.000600
Zima, A. V., Copello, J. A., and Blatter, L. A. (2004). Effects of cytosolic
NADH/NAD(+) levels on sarcoplasmic reticulum Ca(2+) release in
permeabilized rat ventricular myocytes. J. Physiol. 555, 727–741. doi:
10.1113/jphysiol.2003.055848
Zorov, D. B., Filburn, C. R., Klotz, L. O., Zweier, J. L., and Sollott, S. J. (2000).
Reactive oxygen species (ROS)-induced ROS release: a new phenomenon
accompanying induction of the mitochondrial permeability transition in
cardiac myocytes. J. Exp. Med. 192, 1001–1014. doi: 10.1084/jem.192.
7.1001
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
The reviewer QY and handling Editor declared their shared affiliation, and
the handling Editor states that the process nevertheless met the standards of a fair
and objective review.
Copyright © 2016 Tse, Yan, Chan, Tian and Huang. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) or licensor are credited and that the original publication in this
journal is cited, in accordance with accepted academic practice. No use, distribution
or reproduction is permitted which does not comply with these terms.
Frontiers in Physiology | www.frontiersin.org 11 August 2016 | Volume 7 | Article 313
